Correspondence to Dr Karim F Damji, Department of Ophthalmology and Visual Sciences, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada; kdamji{at}ualberta.ca ...
1 Singapore National Eye Centre, 11 Third Hospital Avenue, Singapore 139651, Singapore Eye Research Institute, Republic of Singapore, and the Institute of Ophthalmology, Bath Street, London EC1V 9EL, ...
Correspondence to Professor Yehong Zhuo, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual ...
AIM To evaluate the optical coherence tomographic characteristics of choroidal neovascularisation (CNV) in age related macular degeneration (AMD) and in idiopathic and inflammatory CNV. The use of ...
1 The Institute for Neurology and Neurosurgery, Beth Israel Medical Center, the New York Eye and Ear Infirmary New York, USA 2 The New York Eye and Ear Infirmary Correspondence to: Mark J Kupersmith, ...
Background: Neovascular age-related macular degeneration (AMD) has a poor prognosis if left untreated, frequently resulting in legal blindness. Ranibizumab is approved for treating neovascular AMD.
Aims To evaluate the 1-year efficacy of two new myopia control spectacle lenses with lenslets of different asphericity. Methods One hundred seventy schoolchildren aged 8–13 years with myopia of −0.75 ...
Dr K A Miszkiel, Lysholm Department of Radiology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG BACKGROUND Orbital xanthogranuloma, a diagnosis confirmed ...
2 Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China Background Myopia is a pervasive global public health concern, ...
BACKGROUND/AIMS Hyaluronan (sodium hyaluronate) has been shown to confer objective and subjective improvement in patients with dry eye syndrome. This study compared the efficacy and safety of a 0.1% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results